Urine Eosinophil-Derived Neurotoxin Declines Following Mepolizumab Treatment in Subjects With Eosinophilic Granulomatosis With Polyangiitis

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pharmacogenetic Investigation of Efficacy Response to Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

Rheumatology International
RheumatologyAllergyImmunology
2020English

Eosinophilic Granulomatosis With Polyangiitis - Toward Personalized Treatment

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Familial Eosinophilic Granulomatosis With Polyangiitis

Open Journal of Rheumatology and Autoimmune Diseases
2017English

Eosinophilic Granulomatosis With Polyangiitis: Diagnostic Dilemmas

Internal Medicine
2018English

ANCA-Negative Eosinophilic Granulomatosis With Polyangiitis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Eosinophilic Granulomatosis With Polyangiitis: An Overview

Frontiers in Immunology
AllergyImmunology
2014English

OP0130 Mepolizumab for the Treatment of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomised, Placebo-Controlled Trial

2017English

295. Cardiovascular Disease in Eosinophilic Granulomatosis With Polyangiitis

Rheumatology
RheumatologyPharmacology
2019English

A Case of Eosinophilic Granulomatosis With Polyangiitis

The Medicine Forum
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy